Double maintains 2 strategies that include VERA - Vera Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 48.91% | $1.97B | -26.65% | 0.00% |
CRNX | 47.22% | $2.86B | -32.73% | 0.00% |
XNCR | 45.09% | $550.51M | -67.62% | 0.00% |
ROIV | 44.69% | $8.06B | +8.76% | 0.00% |
PDFS | 43.75% | $716.65M | -49.12% | 0.00% |
COGT | 43.23% | $627.35M | -24.42% | 0.00% |
CLDX | 42.50% | $1.32B | -40.99% | 0.00% |
NUVL | 42.38% | $5.37B | +12.45% | 0.00% |
XENE | 42.27% | $2.23B | -25.61% | 0.00% |
IDYA | 42.24% | $1.76B | -43.98% | 0.00% |
ATXS | 42.01% | $279.35M | -45.06% | 0.00% |
DOCN | 41.67% | $2.54B | -24.13% | 0.00% |
INFA | 41.37% | $7.27B | -16.29% | 0.00% |
BN | 41.24% | $95.08B | +35.28% | 0.57% |
RGNX | 41.04% | $449.94M | -37.49% | 0.00% |
BNT | 40.93% | $11.60B | +35.15% | 0.00% |
COHU | 40.69% | $821.70M | -44.94% | 0.00% |
KRYS | 40.39% | $3.63B | -22.27% | 0.00% |
IR | 40.36% | $33.14B | -10.71% | 0.10% |
BHVN | 40.07% | $1.51B | -58.16% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EVGO | -0.27% | $527.28M | +88.94% | 0.00% |
VSTA | -0.27% | $326.42M | +15.63% | 0.00% |
STG | -0.37% | $27.62M | -29.46% | 0.00% |
AEP | -0.40% | $54.77B | +16.30% | 3.58% |
CPSH | -0.53% | $44.45M | +76.88% | 0.00% |
AGL | 0.57% | $923.11M | -64.26% | 0.00% |
X | 0.64% | $12.05B | +39.64% | 0.38% |
VHC | -0.67% | $33.26M | +91.41% | 0.00% |
USM | -0.68% | $5.26B | +22.02% | 0.00% |
IMNN | -0.79% | $34.91M | +36.30% | 0.00% |
PPC | -1.15% | $11.62B | +54.56% | 0.00% |
BCE | -1.17% | $19.82B | -36.13% | 13.27% |
CYD | -1.19% | $652.82M | +104.47% | 2.19% |
FUBO | 1.21% | $1.24B | +189.60% | 0.00% |
CL | 1.26% | $74.80B | +1.51% | 2.18% |
IMAB | 1.27% | $99.47M | -27.59% | 0.00% |
CYCN | 1.54% | $8.89M | +0.73% | 0.00% |
KLG | 1.73% | $1.47B | -10.05% | 3.80% |
BNED | -1.75% | $407.96M | -84.37% | 0.00% |
AWK | -1.78% | $27.60B | +12.08% | 2.21% |
Finnhub
R&D Day October 2, 2024 © 2024 VERA THERAPEUTICS, INC. ...
SeekingAlpha
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug
Yahoo
BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 111,750 shares of Class A common stock and restricted stock units (RSUs) for 62,575 shares of Class A common stock to eleven (11) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’
Yahoo
On track to announce the primary endpoint results from the atacicept pivotal Phase 3 ORIGIN trial in IgA Nephropathy (IgAN) in 2Q 2025; planning for Biologics License Application (BLA) submission for atacicept accelerated approval to the U.S. FDA in 4Q 2025Expanded atacicept development program across multiple autoimmune kidney diseases is underway BRISBANE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on dev
Finnhub
BRISBANE - Vera Therapeutics, Inc. today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of...
Yahoo
Vera Therapeutics, Inc. (NASDAQ:VERA) said on Wednesday that it had completed full enrollment (431 participants) in the pivotal ORIGIN Phase 3 trial of atacicept in patients with IgA Nephropathy (IgAN). ORIGIN 3 follows the long-term results from the ORIGIN Phase 2b trial, which demonstrated sustained and substantial reductions in Gd-IgA1, hematuria, and proteinuria and showed stabilized kidney function through 96 weeks. The company anticipates the 36-week primary efficacy endpoint data from the
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JPST | 0.06% | $31.04B | 0.18% |
BILZ | 0.07% | $843.92M | 0.14% |
IBTF | 0.09% | $2.10B | 0.07% |
FTSM | -0.18% | $6.50B | 0.45% |
BSV | -0.21% | $38.07B | 0.03% |
OILK | -0.37% | $60.50M | 0.69% |
JMST | 0.45% | $3.76B | 0.18% |
GTIP | -0.47% | $147.06M | 0.12% |
GOVT | 0.60% | $27.36B | 0.05% |
UNG | -0.74% | $368.09M | 1.06% |
LDUR | -0.83% | $911.83M | 0.5% |
GOVZ | 0.83% | $259.84M | 0.1% |
LGOV | -0.86% | $688.41M | 0.67% |
STXT | -0.86% | $136.16M | 0.49% |
BSMW | 0.87% | $102.11M | 0.18% |
IBTP | -0.88% | $132.62M | 0.07% |
USFR | -0.97% | $18.83B | 0.15% |
TDTF | 1.03% | $806.22M | 0.18% |
USO | -1.13% | $874.61M | 0.6% |
GSST | 1.19% | $884.31M | 0.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -33.60% | $111.21M | 0.59% |
VIXY | -30.50% | $141.70M | 0.85% |
BTAL | -28.85% | $320.45M | 1.43% |
IVOL | -15.29% | $348.07M | 1.02% |
FTSD | -14.65% | $212.84M | 0.25% |
KCCA | -13.25% | $94.38M | 0.87% |
WEAT | -11.36% | $118.99M | 0.28% |
XONE | -9.77% | $616.52M | 0.03% |
FXY | -9.50% | $858.65M | 0.4% |
SPTS | -9.37% | $5.74B | 0.03% |
STPZ | -8.45% | $453.91M | 0.2% |
GBIL | -8.31% | $6.08B | 0.12% |
ULST | -8.27% | $660.43M | 0.2% |
TFLO | -8.23% | $7.03B | 0.15% |
TPMN | -7.73% | $30.91M | 0.65% |
CARY | -7.63% | $347.36M | 0.8% |
UTWO | -7.58% | $380.80M | 0.15% |
CANE | -7.56% | $10.83M | 0.29% |
VTIP | -6.94% | $14.92B | 0.03% |
SCHO | -6.08% | $10.93B | 0.03% |
Current Value
$19.681 Year Return
Current Value
$19.681 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -17.62% | $24.46M | -56.54% | 0.00% |
FMTO | -13.04% | $37.82M | -99.94% | 0.00% |
HUSA | -7.59% | $7.53M | -63.36% | 0.00% |
BULL | -6.57% | $5.74B | +12.27% | 0.00% |
AQB | -6.21% | $3.55M | -49.09% | 0.00% |
MKTX | -5.95% | $8.03B | +8.29% | 1.40% |
AIFU | -5.38% | $2.64B | -23.13% | 0.00% |
PRT | -4.84% | $49.15M | +4.94% | 11.06% |
ED | -4.61% | $37.25B | +11.82% | 3.26% |
EXC | -4.14% | $44.12B | +18.98% | 3.56% |
VRCA | -4.12% | $50.40M | -93.46% | 0.00% |
WBA | -4.02% | $9.72B | -27.00% | 4.47% |
VSA | -3.95% | $6.89M | -41.29% | 0.00% |
DOGZ | -3.83% | $313.43M | +130.31% | 0.00% |
KR | -3.27% | $44.58B | +28.80% | 1.91% |
CORT | -3.00% | $8.23B | +148.77% | 0.00% |
NEUE | -2.64% | $61.16M | +13.41% | 0.00% |
K | -1.88% | $28.62B | +39.03% | 2.75% |
AWK | -1.78% | $27.60B | +12.08% | 2.21% |
BNED | -1.75% | $407.96M | -84.37% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 55.85% | $4.60B | 0.35% |
IBB | 50.88% | $5.23B | 0.45% |
PBE | 47.66% | $223.00M | 0.58% |
GNOM | 47.36% | $41.00M | 0.5% |
PINK | 46.70% | $130.02M | 0.5% |
IWO | 45.97% | $11.24B | 0.24% |
XT | 45.62% | $3.24B | 0.46% |
PTH | 45.25% | $97.74M | 0.6% |
CLOU | 45.20% | $334.51M | 0.68% |
BBH | 44.88% | $330.20M | 0.35% |
KJUL | 44.47% | $115.62M | 0.79% |
ISCG | 44.31% | $658.37M | 0.06% |
VT | 44.10% | $45.82B | 0.06% |
DFAW | 44.04% | $707.00M | 0.25% |
SPGM | 43.99% | $1.05B | 0.09% |
VBK | 43.95% | $18.20B | 0.07% |
KOMP | 43.71% | $2.18B | 0.2% |
XPH | 43.54% | $138.73M | 0.35% |
VTWO | 43.49% | $12.05B | 0.07% |
SCHA | 43.43% | $16.81B | 0.04% |